{"filings":[{"id":1083836,"accession_number":"0001628280-26-043537","cik":1611115,"company_name":"Omada Health, Inc.","ticker":"OMDA","form_type":"8-K","filed_at":"2026-06-16T20:08:13+00:00","items":["5.07"],"status":"ready","headline":"Omada Health stockholders elect Duffy and Fetter as Class I directors, ratify Deloitte auditor for FY2026","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Sean Duffy elected with 18,540,089 votes for, 9,134,162 withheld; 13,920,625 broker non-votes.","Trevor Fetter elected with 18,538,042 votes for, 9,136,209 withheld; 13,920,625 broker non-votes.","Auditor Deloitte & Touche LLP ratified with 41,550,689 votes for, 16,905 against, 27,282 abstain.","Meeting held June 16, 2026; record date April 20, 2026; proxy statement filed April 28, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1019839118.5956866,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94084,"accession_number":"0001628280-26-032063","cik":1611115,"company_name":"Omada Health, Inc.","ticker":"OMDA","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omada Health Q1 revenue $78M (+42% YoY); members top 1M, net loss narrows to $3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $78M, up 42% YoY; total members 1.02M, up 51% YoY.","Net loss $3M vs $9M in Q1 2025; adjusted EBITDA positive $1M vs -$4M.","Joined Optum Rx Weight Engage; now relationships with all three top PBMs covering 80% of U.S. prescription claims.","Gross margin 62% (non-GAAP 64%), up from 58% (non-GAAP 60%) YoY.","Announced independent program administrator for Eli Lilly Employer Connect; GLP-1 Care Track data shows 1.8x weight loss."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":78048000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1019839118.5956866,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106198,"accession_number":"0001628280-26-015153","cik":1611115,"company_name":"Omada Health, Inc.","ticker":"OMDA","form_type":"8-K","filed_at":"2026-03-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omada Health Q4 revenue $76M (+58% YoY), achieves positive net income of $5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $76M (+58% YoY); full-year $260M (+53% YoY). GAAP net income $5M in Q4 vs ($8M) loss prior year.","Full-year net loss narrowed to $13M from $47M; adjusted EBITDA turned positive at $6M vs ($29M) in 2024.","Total members reached 886,000 (+55% YoY); GLP-1 supported members tripled to over 150,000.","Gross margin improved: Q4 GAAP 71% (up from 67%), full-year 66% (up from 61%).","Launched new products: GLP-1 Flex Care, OmadaSpark, Meal Map, and Omada for Cholesterol (Feb 2026)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1019839118.5956866,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106197,"accession_number":"0001628280-26-001781","cik":1611115,"company_name":"Omada Health, Inc.","ticker":"OMDA","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omada Health reports preliminary Q4 revenue $72-74M, FY 2025 revenue $256-258M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 preliminary revenue $72-74M, up 50-54% YoY; FY 2025 revenue $256-258M, up 51-52%.","Total members reached ~886,000 as of Dec 31, 2025, a 55% YoY increase.","Results are unaudited and subject to adjustment; audited results expected March 5, 2026.","CEO cites enhanced GLP-1 care offerings and AI platform advancements as growth drivers."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":260210000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1019839118.5956866,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":122480,"accession_number":"0001628280-25-050158","cik":1611115,"company_name":"Omada Health, Inc.","ticker":"OMDA","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omada Health Q3 revenue $68M (+49% YoY); first positive adjusted EBITDA $2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $68M, up 49% YoY; members 831K, up 53% YoY.","Net loss $3M vs $9M loss prior year; first quarter of positive adjusted EBITDA of $2M.","Gross margin 66% (non-GAAP 68%), up from 63% (65%) in Q3 2024.","Announced new GLP-1 prescribing offering combining behavior change with anti-obesity medications.","Cash and equivalents $199M at quarter end."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.61,"consensus_revenue_estimate":null,"consensus_revenue_actual":184364000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1019839118.5956866,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":139174,"accession_number":"0001611115-25-000013","cik":1611115,"company_name":"Omada Health, Inc.","ticker":"OMDA","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omada Health Q2 revenue up 49% to $61M; net loss narrows to $5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $61M (+49% YoY); members 752K (+52% YoY).","Gross margin 66% (vs 60% Q2'24); non-GAAP gross margin 68%.","Net loss $5M (vs $11M loss Q2'24); adjusted EBITDA loss $0.2M (vs $6.8M).","Cash and equivalents $223M; GLP-1 companion programs expanding.","Launched OmadaSpark AI agent for real-time motivational coaching."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.98,"consensus_revenue_estimate":null,"consensus_revenue_actual":116334000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1019839118.5956866,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":156721,"accession_number":"0001193125-25-137809","cik":1611115,"company_name":"Omada Health, Inc.","ticker":"OMDA","form_type":"8-K","filed_at":"2025-06-09T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Omada Health completes IPO of 9.085M shares at $19.00, raising $172.6M gross","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["IPO of 9,085,000 shares at $19.00 per share, including full exercise of underwriter option for 1,185,000 shares.","Gross proceeds to Omada Health were $172,615,000 before underwriting discounts and expenses.","Restated certificate of incorporation and amended bylaws filed effective upon IPO closing.","IPO closed on June 9, 2025; shares trade on Nasdaq under ticker OMDA."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1019839118.5956866,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}